The influence of polymorphism of -493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress
Abstract
The aim of this study was to investigate the effect of the microsomal triglyceride transfer protein (MTP) -493G/T polymorphism on clinical and biochemical parameters in relation to the presence of metabolic syndrome (MS). A group of 270 participants, 143 men and 127 women [50 men/36 women fulfilled the International Diabetes Federation (IDF) criteria of MS], was categorized on the basis of the MTP -493G/T polymorphism: GG homozygotes (Group GG) and carriers of the T allele (Group TT+TG).
In men with MS, the presence of the T allele was associated with elevated concentrations of plasma insulin (by 48%, P <.01) and nonesterified fatty acids (by 49%, P <.05); homcostasis model assessment for insulin resistance index was higher by 64% (P <.05). Carriers of the T allele were further characterized by elevated plasma concentrations of total cholesterol (by 14%, P <.05) and by increased triglycerides in plasma (by 95%, P <.01) and in very low-density lipoprotein (by 106%, P <.01).
They also had lower concentrations of n-6 polyunsaturated fatty acids in plasma phospholipids (by 3.5%, P <.05), lower Delta 5-desaturase activities (by 18%, P <.05) and elevated concentrations of conjugated dienes in low-density lipoprotein (by 29%, P <.01). No significant differences between Groups GG and TT+TG were found in men without MS and in women with and without MS.
Our results imply evidence for interactive effects of genetic, metabolic and gender-specific factors on several components of metabolic syndrome, which can increase the risk for cardiovascular disease.